Finance

Beta
Lists
HUMA:NASDAQ
Humacyte Inc
$1.38
+2.22%
(+0.030) 1D
$1.37
-0.72% (-0.0100)
After hours
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HUMA...
Open
$1.40
High
$1.42
Low
$1.35
Mkt. cap
306.39M
Avg. vol.
6.93M
Volume
3.77M
52-wk high
$2.84
52-wk low
$0.55
EPS
-$0.57
Beta
2.45
Shares outstanding
222.02M
No. of employees
184
Open
$1.40
High
$1.42
Low
$1.35
Mkt. cap
306.39M
Avg. vol.
6.93M
Volume
3.77M
52-wk high
$2.84
52-wk low
$0.55
EPS
-$0.57
Beta
2.45
Shares outstanding
222.02M
No. of employees
184
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to HUMA in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for HUMA in the last 3 months.
Highest
Current $1.38
$6.00 (+334.78%)
Average
$2.50 (+81.16%)
Lowest
$1.00 (-27.54%)
News stories
From sources across the web
About Humacyte Inc
CEOLaura Niklason
Employees184
FoundedJan 1, 2004
Headquarters-
SectorBiotechnology
Last report
May 13, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.09 / -$0.12
+21.74%beat
Revenue / Est. (USD)
495.00K / 1.46M
-66.20%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
301.00K
753.00K
467.00K
495.00K
Cost of goods sold
22.22M
17.53M
23.69M
20.90M
Cost of revenue
22.22M
17.53M
23.69M
20.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.81M
7.61M
7.62M
7.83M
Operating expense
7.81M
7.61M
7.62M
7.83M
Total operating expenses
30.03M
25.14M
31.30M
28.73M
Operating income
-29.73M
-24.39M
-30.84M
-28.24M
Other non operating income
-748.00K
4.01M
20.57M
8.52M
EBT including unusual items
-37.66M
-17.51M
-24.80M
-17.62M
EBT excluding unusual items
-32.19M
-22.40M
-12.85M
-21.65M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-37.66M
-17.51M
-24.80M
-17.62M
Net profit margin
-12,510.96%
-2,325.37%
-5,311.35%
-3,559.39%
Earnings per share
-0.24
-0.11
-0.13
-0.09
Interest and investment income
832.00K
590.00K
503.00K
330.00K
Interest expense
-2.54M
-2.61M
-3.09M
-2.27M
Net interest expenses
-1.71M
-2.02M
-2.59M
-1.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.87M
-22.52M
-29.05M
-26.44M
Gain or loss from assets sale
-
-
5.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more